

HY-P99961 · 1 mg
MedChemExpress · Cat: HY-P99961
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/tifcemalimab.html
Description
Tifcemalimab JS004 is a humanized anti-BTLA B and T lymphocyte attenuation factor monoclonal antibody. Tifcemalimab blocks the interaction of HVEM-BTLA by binding to BTLA, and thus blocks the inhibitory signaling pathway mediated by BTLA. Tifcemalimab can be used in research of cancer, such as lymphoma and non-small cell lung cancer NSCLC .







